Hetero Labs' Acarbose-Sitagliptin-Metformin FDC Rejected by CDSCO Panel Over GI Risk Dr. Divya Colin30 Jun 2025 5:45 PM ISTNew Delhi: In a setback to Hetero Labs Limited, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation...
CDSCO Clears Abbott's phase IV Trial Of Dydrogesterone MR Tablet Parthika Patel30 Jun 2025 2:53 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organization (CDSCO) has approved...
Intas Gets SEC Nod to Import, Market Anti-Cancer Drug Serplulimab, Phase IV Trial Mandated Dr. Divya Colin29 Jun 2025 1:00 PM ISTNew Delhi: Intas Pharmaceutical has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Abbott Gets SEC Nod to Market Chlordiazepoxide Tablets for Anxiety, Alcohol Withdrawal Dr. Divya Colin28 Jun 2025 7:44 PM ISTNew Delhi: Abbott Healthcare has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Pfizer Gets CDSCO Panel Nod to Conduct Phase IIIb Trial of Rimegepant for Menstrual Migraine Parthika Patel28 Jun 2025 7:23 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has granted Pfizer Limited...
Akums Gets CDSCO Panel Nod for BE Study of Rizatriptan-Meloxicam FDC, Told to Revise Phase III Protocol Dr. Divya Colin27 Jun 2025 11:07 PM ISTNew Delhi: In response to the proposal presented by the Akums Drugs & Pharmaceuticals along with BE and Phase III clinical trial protocol of the...
CDSCO Asks Serum Institute to Revise Protocol for Trivalent Flu-COVID Vaccine Trial Parthika Patel27 Jun 2025 10:53 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the COVID-19 division of the Central Drugs Standard Control Organization (CDSCO) has reviewed a...
Health Ministry Plans Licence Suspension for Drugs Failing Quality Standards: Report Farhat Nasim26 Jun 2025 8:01 PM ISTNew Delhi: The Union Health Ministry is planning a regulatory overhaul that could result in the immediate suspension of product licenses for...
Bharat Serums Gets CDSCO Panel Nod for Phase III Trial of IVIG in Chronic ITP Dr. Divya Colin26 Jun 2025 7:57 PM ISTNew Delhi: Bharat Serums and Vaccines has received approval from the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
SEC Clears Hemopurifier Device for Cancer Study in Indian Patients Parthika Patel26 Jun 2025 7:50 PM ISTNew Delhi: In a step toward advancing medical device-based cancer care, the Subject Expert Committee (SEC) under the Oncology division of the Central...
Label Update for AstraZeneca's Olaparib Cleared by CDSCO Panel Parthika Patel25 Jun 2025 5:11 PM ISTNew Delhi: In a recent regulatory update, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control...
Biocon Gets CDSCO Panel Nod to Market Trastuzumab PGS in India Dr. Divya Colin25 Jun 2025 4:51 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Oncology and Hematology, functioning under the Central Drugs Standard Control Organisation (CDSCO),...
